National Health Investors (NYSE:NHI) Announces Earnings Results

National Health Investors (NYSE:NHI) announced its quarterly earnings results on Thursday. The real estate investment trust reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.08, Zacks reports. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The company had revenue of $83.36 million for the quarter, compared to analyst estimates of $85.66 million. During the same quarter last year, the business earned $1.03 EPS. National Health Investors’s revenue for the quarter was down 1.8% on a year-over-year basis. National Health Investors updated its FY 2025 guidance to 4.880-4.91 EPS.

National Health Investors Stock Up 2.2%

National Health Investors stock traded up $1.66 during midday trading on Friday, hitting $76.97. 423,563 shares of the stock were exchanged, compared to its average volume of 238,050. National Health Investors has a 1 year low of $65.13 and a 1 year high of $82.32. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91. The firm has a market cap of $3.65 billion, a P/E ratio of 24.59, a P/E/G ratio of 3.31 and a beta of 0.74. The company has a 50 day moving average price of $76.78 and a two-hundred day moving average price of $74.38.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date of this dividend is Wednesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is presently 117.57%.

Institutional Trading of National Health Investors

A number of hedge funds and other institutional investors have recently modified their holdings of NHI. Balyasny Asset Management L.P. lifted its holdings in shares of National Health Investors by 66.9% in the 2nd quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock worth $43,121,000 after purchasing an additional 246,486 shares during the last quarter. Qube Research & Technologies Ltd increased its position in National Health Investors by 86.0% in the second quarter. Qube Research & Technologies Ltd now owns 319,286 shares of the real estate investment trust’s stock worth $22,388,000 after buying an additional 147,591 shares during the period. State Street Corp boosted its holdings in shares of National Health Investors by 5.0% during the second quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock valued at $143,651,000 after acquiring an additional 95,812 shares during the period. Jane Street Group LLC grew its position in shares of National Health Investors by 1,728.4% during the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock worth $5,148,000 after acquiring an additional 65,885 shares during the last quarter. Finally, Cubist Systematic Strategies LLC increased its holdings in shares of National Health Investors by 137.6% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 71,845 shares of the real estate investment trust’s stock worth $5,038,000 after acquiring an additional 41,609 shares during the period. 62.51% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently weighed in on NHI. Wells Fargo & Company increased their target price on National Health Investors from $76.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Wednesday, August 27th. Cantor Fitzgerald began coverage on National Health Investors in a report on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 price objective on the stock. Truist Financial lifted their price objective on National Health Investors from $77.00 to $81.00 and gave the company a “buy” rating in a research note on Friday, August 15th. Weiss Ratings reissued a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday, October 8th. Finally, National Bankshares set a $90.00 price target on shares of National Health Investors in a report on Wednesday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $84.83.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.